Female and male infertility

Ensure the healthy future

Contact Us

Please fill in this form for additional information on treatment, procedures, price, etc.

About Treatment

The statistics on reproductive health of men and women is disappointing – about 10% of women in the United States (6 million) have difficulties getting or staying pregnant and about 8% of men experience fertility problems. In general, 1 in 6 couples in the US cannot conceive a child. Fertility declines with age in both men and women but there are also some other causes and risk factors, such as genetic disorders, previous diseases, and medications, overexposure to certain environmental factors, being overweight or underweight, unhealthy habits, etc. Stem cell therapy has shown promising results in the treatment of reproductive health disorders. Researchers of Stanford Institute for Stem Cell Biology and Regenerative Medicine have used stem cell technologies to turn skin cells of infertile men into early-stage spermatozoids. This revolutionary discovery is a real breakthrough because men infertility caused by different defects of spermatozoids was considered incurable before. The method of treating male and female infertility with autologous (patient’s own) stem cells is aimed at eliminating the cause of the disorder. Often infertility is caused by past infectious or inflammatory diseases and immune dysfunction. Stem cells restore the immune system of the patient and show excellent results in the treatment of infertility. Today the most effective and safe method of treating reproductive system disorders is cellular, regenerative therapy.

Improvements

Improvements that can be expected after stem cell therapy:

Sperm count increase, significant improvement of semen quality

Improvement of nervous and endocrine systems functioning

Female fertility boost

Stimulation of the immune system

Normalization of the menstrual cycle

Activation of the ovarian function

Uterine function normalization

Consultation from a doctor for free

Get advice from a leading specialist and find out how stem cells will help you.

  • Avril

    Age: 41

    Country: Canada

    Infertility Treatment

    I am 34 years old, from Canada. I could not become pregnant and even in-vitro fertilization failed to help me. After medical examination in the Infinity Clinic it become clear that that infertility is caused by impairment of my hormonal system. Before the treatment with fetal stem cells, levels of my follicle-stimulating hormone and luteinizing hormone were 5,39 and 2,92 respectively (closer to menopause reference rates). And level of my AMH was 0,348 (very low ovarian function). After the treatment in Infinity Clinic function of my hormonal system significantly improved! Levels of the follicle-stimulating hormone was 2,63, level of luteinizing hormone was 10,74 and level of AMH was 1,008. So, now I have a chance to become pregnant in a natural way!

    Infinity Clinic

The association of female and male infertility with telomere length (Review)

https://www.researchgate.net/publication/333518711_The_association_of_female_and_male_infertility_with_telomere_length_Review

Telomere length (TL) has long been associated with aging, as telomeres serve as protective caps of chromosomes, and are thus deeply involved in the preservation of genome integrity and are vital to cellular functions. Traditionally, a strong link connects aging and infertility in both sexes, with an earlier onset in females. Over the past decade, telomeres have attracted increasing attention due to the role they play in fertility. In this review, we investigated the potential positive or negative association between relative TL and different factors of female and male infertility. A systematic search of the PubMed database was conducted. Out of the 206 studies identified, 45 were reviewed as they fulfilled the criteria of validity and relevance. Following an analysis and a comparison of the study outcomes, several clear trends were observed. The majority of female infertility factors were associated with a shorter TL, with the exception of endometriosis, premature ovarian failure and clear cell carcinoma that were associated with a longer TL and polycystic ovary syndrome (PCOS), which revealed conflicting results among several studies, leading to ambiguous conclusions. Male infertility factors were associated with a shorter TL. Although this review can provide an outline of general trends in the association of TL with infertility factors, further epidemiological and original research studies are required to focus on investigating the basis of these varying lengths of telomeres.

MESENCHYMAL STEM CELLS TREATMENT OF MALE INFERTILITY

https://www.researchgate.net/publication/326557036_MESENCHYMAL_STEM_CELLS_TREATMENT_OF_MALE_INFERTILITY

The present study was conducted to investigate the ability of mice bone marrow mesenchymal stem cells to treat male infertility induced by cyclophosphamide injected in the caudal vein of albino male mice. The study was carried out on 30 albino male and 10 female mice obtained from Theodore Bilhariz Research Institute, Ministry of Scientific Research, Giza, Egypt. The mice were acclimatized then subdivided into three groups each contains 10 mice each with an average body weight 23-25 g ; group(1); normal control, Group (2) male infertility induced group with Cyclophosphamide untreated and group (3) male infertility induced group and treated with mesenchymal stem cell isolated from bone marrow blood. Male infertility induction takes by obtaining a loading dose 50 mg / kg at 24 h, then rotating dose 8 mg/kg for14 days constantly. Data obtained from the study showed that Seminiferous tubules of mouse testis were damaged in group (2) after male infertility induction by CTX. However follicle stimulating hormone (FSH) was significantly with high values in pc-ctx group observed after 36 days but increased with Slightly values in tscs group. In addition to testosterone obtained in two assay total and free, total testerone was decreasing with high values in pc-ctx group observed after 36 days but decreasing with slightly values in tscs group. However free testerone was decreasing with high values in pc-ctx group observed after 36 days but decreasing with slightly values in tscs group. In another side histological assay in pc-ctx group demonstrated that seminifrous tubes was damaged in spermatogonia and other germinal cells but in tscs was slight destruction. The results showed that after induction mice has been induced induction but repairing after stem cells treatment.